Business Context and Reporting Period
Company: Capricor Therapeutics, Inc.
Filing Type: Form 8-K (Current Report)
Date: November 14, 2019
Event: Regulation FD Disclosure regarding the posting of a corporate presentation on the Company's website updating current business and products.
Financial Metrics
This filing is a disclosure of a corporate presentation and does not contain specific financial statements. The text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational metrics are detailed within the text of this Form 8-K. The filing serves solely to incorporate by reference an attached slide presentation (Exhibit 99.1) containing business updates.
Guidance, Outlook, and Risks
Management Commentary: The Company posted a corporate presentation to its "Investors" section to provide an update on its business and products.
Legal Status: The information in Item 7.01 is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it subject to the liabilities of that section, except as expressly set forth by specific reference.
Key Facts for Investor Verification
- Verify the content of the attached Exhibit 99.1 (Corporate Presentation dated November 14, 2019) for specific business updates, as the 8-K text only references the document.
- Confirm the trading symbol (CAPR) and exchange (The Nasdaq Capital Market) for the Company's common stock.
- Note that the filing does not include audited financial data or specific forward-looking guidance within the report text itself.